These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 16203286)
21. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations. Aubry MC; Heinrich MC; Molina J; Lewis JE; Yang P; Cassivi SD; Corless CL Cancer; 2007 Dec; 110(11):2507-10. PubMed ID: 17932891 [TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mastropasqua MG; Maiorano E; Pruneri G; Orvieto E; Mazzarol G; Vento AR; Viale G Mod Pathol; 2005 Oct; 18(10):1277-82. PubMed ID: 15846389 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466 [TBL] [Abstract][Full Text] [Related]
24. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
25. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. Pan CC; Chen PC; Chiang H J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904 [TBL] [Abstract][Full Text] [Related]
26. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Brown JG; Familiari U; Papotti M; Rosai J Am J Surg Pathol; 2009 Aug; 33(8):1113-24. PubMed ID: 19461509 [TBL] [Abstract][Full Text] [Related]
27. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202 [TBL] [Abstract][Full Text] [Related]
28. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Albores-Saavedra J; Heard SC; McLaren B; Kamino H; Witkiewicz AK Am J Clin Pathol; 2005 Jun; 123(6):866-73. PubMed ID: 15899777 [TBL] [Abstract][Full Text] [Related]
29. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424 [TBL] [Abstract][Full Text] [Related]
30. [Adenoid basal carcinoma and adenoid cystic carcinoma of the uterine cervix]. Lefrancq T; de Muret A; Michalak S; Lhuintre Y; Fetissof F Ann Pathol; 1997 Jul; 17(3):196-9. PubMed ID: 9296580 [TBL] [Abstract][Full Text] [Related]
31. Is c-kit (CD117) immunolocalization in cell block preparations useful in the differentiation of adenoid cystic carcinoma from pleomorphic adenoma? Chandan VS; Wilbur D; Faquin WC; Khurana KK Cancer; 2004 Aug; 102(4):207-9. PubMed ID: 15368311 [No Abstract] [Full Text] [Related]
32. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394 [TBL] [Abstract][Full Text] [Related]
33. Thymic tumor with adenoid cystic carcinomalike features: a clinicopathologic study of 4 cases. Di Tommaso L; Kuhn E; Kurrer M; Zettl A; Marx A; Müller-Hermelink HK; Roncalli M; Rosai J Am J Surg Pathol; 2007 Aug; 31(8):1161-7. PubMed ID: 17667537 [TBL] [Abstract][Full Text] [Related]
34. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands. Alves SM; Cardoso SV; de Fátima Bernardes V; Machado VC; Mesquita RA; Vieira do Carmo MA; Ferreira Aguiar MC Oral Oncol; 2007 Mar; 43(3):252-6. PubMed ID: 16857408 [TBL] [Abstract][Full Text] [Related]
35. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128 [TBL] [Abstract][Full Text] [Related]
37. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland]. You JQ; Wang P Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739 [TBL] [Abstract][Full Text] [Related]
38. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Zhang YG; DU J; Tian XX; Zhong YF; Fang WG Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479 [TBL] [Abstract][Full Text] [Related]
39. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
40. Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands. Kiss O; Tőkés AM; Vranic S; Gatalica Z; Vass L; Udvarhelyi N; Szász AM; Kulka J Virchows Arch; 2015 Nov; 467(5):551-62. PubMed ID: 26293217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]